Results 21 to 30 of about 4,120 (162)

Lanthanum carbonate for hyperphosphatemia in patients on peritoneal dialysis. [PDF]

open access: greenPerit Dial Int, 2013
Ohno M   +8 more
europepmc   +2 more sources

Gastropathy associated with lanthanum phosphate deposition that was endoscopically tracked for 3 years. A case report

open access: yesBMC Gastroenterology, 2020
Background With the recent increased use of lanthanum carbonate, several cases of lanthanum phosphate deposition to gastric mucosa in dialysis patients have been reported.
Akiko Ohno   +8 more
doaj   +1 more source

The Pharmacological Effect and Mechanism of Lanthanum Hydroxide on Vascular Calcification Caused by Chronic Renal Failure Hyperphosphatemia

open access: yesFrontiers in Cell and Developmental Biology, 2021
ObjectiveThe present work aimed to explore the efficacy of lanthanum hydroxide in managing the vascular calcification induced by hyperphosphate in chronic renal failure (CRF) as well as the underlying mechanism.MethodsRats were randomly allocated to five
Lulu Zhao   +12 more
doaj   +1 more source

Novel case of laparoscopically resected gastric adenocarcinoma concurrent with lanthanum deposition

open access: yesClinical Case Reports, 2022
A 73‐year‐old man taking lanthanum carbonate for hemodialysis showed progressing gastric mucosal changes with lanthanum deposition. Regular examination revealed concurrent gastric carcinoma.
Kosuke Hirose   +8 more
doaj   +1 more source

Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study

open access: yesBMC Nephrology, 2011
Background Lanthanum carbonate (FOSRENOL®) is an effective, well-tolerated phosphate binder. The ability of lanthanum to reduce serum phosphorus levels to ≤5.5 mg/dL in patients with end-stage renal disease (ESRD) was assessed in a clinical practice ...
Matalon Albert   +2 more
doaj   +1 more source

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients

open access: yesBMC Nephrology, 2013
Background This short-term study assessed the efficacy and safety of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients; here, we report a prespecified subgroup analysis of patients undergoing peritoneal dialysis.
Hutchison Alastair J   +4 more
doaj   +1 more source

Preparation and Characterization of Lanthanum Carbonate Octahydrate for the Treatment of Hyperphosphatemia

open access: yesJournal of Spectroscopy, 2013
We proposed a new approach to prepare lanthanum carbonate via reactions between lanthanum chloride and NaHCO3. In the reaction, small amount of NaHCO3 solution was firstly added to the acidic lanthanum chloride solution to generate lanthanum carbonate ...
Anqi He   +13 more
doaj   +1 more source

Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China

open access: yesBMC Nephrology, 2013
Background Serum phosphorus control is critical for chronic kidney disease (CKD) 5D patients. Currently, clinical profile for an oral phosphorus binder in the mainland Chinese population is not available.
Xu Jing   +13 more
doaj   +1 more source

Strong adsorption of phosphate by amorphous lanthanum carbonate nano-adsorbents

open access: yesWater Science and Technology, 2021
Phosphorus removal is a crucial aspect of controlling water pollution and eutrophication. In this study, the preparation of lanthanum carbonate (LC) nano-adsorbents for the efficient removal of phosphate (P) from water and wastewater was investigated ...
Yifan Lu, Huawei Wu, Yan Xia, Mei Huang
doaj   +1 more source

A comparison between the combined effect of calcium carbonate with sucroferric oxyhydroxide and other phosphate binders: an in vitro and in vivo experimental study

open access: yesBMC Nephrology, 2019
Background Approximately 30% of patients on dialysis received combination therapy for their phosphate binder prescription; however, few studies for combined effects of phosphate binders are reported.
Atsushi Yaguchi   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy